Richard Newitter
Stock Analyst at Truist Securities
(3.95)
# 564
Out of 5,126 analysts
444
Total ratings
49.44%
Success rate
11.07%
Average return
Main Sectors:
Stocks Rated by Richard Newitter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Maintains: Buy | $120 → $95 | $76.27 | +24.56% | 21 | Feb 5, 2026 | |
| BBNX Beta Bionics | Maintains: Buy | $37 → $25 | $13.08 | +91.13% | 6 | Feb 2, 2026 | |
| PEN Penumbra | Downgrades: Hold | $370 → $374 | $341.02 | +9.67% | 8 | Jan 16, 2026 | |
| INSP Inspire Medical Systems | Maintains: Buy | $165 → $120 | $65.70 | +82.65% | 30 | Jan 8, 2026 | |
| IRTC iRhythm Holdings | Maintains: Buy | $230 → $215 | $146.47 | +46.79% | 19 | Dec 18, 2025 | |
| VCEL Vericel | Maintains: Buy | $50 → $45 | $36.19 | +24.34% | 6 | Dec 18, 2025 | |
| TMCI Treace Medical Concepts | Maintains: Hold | $4 → $3 | $2.26 | +32.74% | 19 | Dec 18, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Hold | $17 → $24 | $19.17 | +25.20% | 4 | Dec 18, 2025 | |
| SYK Stryker | Maintains: Hold | $400 → $392 | $358.29 | +9.41% | 25 | Dec 18, 2025 | |
| PRCT PROCEPT BioRobotics | Maintains: Buy | $50 → $47 | $28.74 | +63.54% | 16 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $110 → $107 | $102.90 | +3.98% | 19 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $82 | $64.89 | +26.37% | 22 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $620 → $650 | $488.15 | +33.16% | 32 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $86 → $95 | $86.45 | +9.89% | 12 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $412 → $390 | $241.93 | +61.20% | 4 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $120 → $145 | $112.52 | +28.87% | 7 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $90 → $92 | $78.71 | +16.88% | 22 | Dec 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $93 → $105 | $87.81 | +19.58% | 30 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 → $20 | $11.67 | +71.38% | 2 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $94 → $82 | $69.97 | +17.19% | 3 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $13 → $15 | $11.26 | +33.21% | 19 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $140 → $137 | $108.42 | +26.36% | 38 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $26 → $24 | $16.65 | +44.14% | 10 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $118 → $113 | $89.91 | +25.68% | 32 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $21 | $15.60 | +34.66% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $8.39 | +138.38% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $71 → $82 | $78.83 | +4.02% | 5 | Aug 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $260 → $250 | $210.02 | +19.04% | 5 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $27 → $26 | $3.77 | +589.66% | 4 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $690 → $770 | $187.60 | +310.45% | 10 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $94 → $85 | $74.81 | +13.62% | 6 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $12.09 | +65.43% | 1 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $27 | $34.92 | -22.68% | 5 | Feb 23, 2021 |
Boston Scientific
Feb 5, 2026
Maintains: Buy
Price Target: $120 → $95
Current: $76.27
Upside: +24.56%
Beta Bionics
Feb 2, 2026
Maintains: Buy
Price Target: $37 → $25
Current: $13.08
Upside: +91.13%
Penumbra
Jan 16, 2026
Downgrades: Hold
Price Target: $370 → $374
Current: $341.02
Upside: +9.67%
Inspire Medical Systems
Jan 8, 2026
Maintains: Buy
Price Target: $165 → $120
Current: $65.70
Upside: +82.65%
iRhythm Holdings
Dec 18, 2025
Maintains: Buy
Price Target: $230 → $215
Current: $146.47
Upside: +46.79%
Vericel
Dec 18, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $36.19
Upside: +24.34%
Treace Medical Concepts
Dec 18, 2025
Maintains: Hold
Price Target: $4 → $3
Current: $2.26
Upside: +32.74%
Tandem Diabetes Care
Dec 18, 2025
Maintains: Hold
Price Target: $17 → $24
Current: $19.17
Upside: +25.20%
Stryker
Dec 18, 2025
Maintains: Hold
Price Target: $400 → $392
Current: $358.29
Upside: +9.41%
PROCEPT BioRobotics
Dec 18, 2025
Maintains: Buy
Price Target: $50 → $47
Current: $28.74
Upside: +63.54%
Dec 18, 2025
Maintains: Hold
Price Target: $110 → $107
Current: $102.90
Upside: +3.98%
Dec 18, 2025
Maintains: Buy
Price Target: $80 → $82
Current: $64.89
Upside: +26.37%
Dec 18, 2025
Maintains: Buy
Price Target: $620 → $650
Current: $488.15
Upside: +33.16%
Dec 18, 2025
Maintains: Buy
Price Target: $86 → $95
Current: $86.45
Upside: +9.89%
Dec 18, 2025
Maintains: Buy
Price Target: $412 → $390
Current: $241.93
Upside: +61.20%
Dec 18, 2025
Maintains: Buy
Price Target: $120 → $145
Current: $112.52
Upside: +28.87%
Dec 5, 2025
Maintains: Hold
Price Target: $90 → $92
Current: $78.71
Upside: +16.88%
Nov 18, 2025
Reiterates: Buy
Price Target: $93 → $105
Current: $87.81
Upside: +19.58%
Nov 7, 2025
Reiterates: Buy
Price Target: $18 → $20
Current: $11.67
Upside: +71.38%
Nov 3, 2025
Reiterates: Buy
Price Target: $94 → $82
Current: $69.97
Upside: +17.19%
Oct 15, 2025
Maintains: Hold
Price Target: $13 → $15
Current: $11.26
Upside: +33.21%
May 5, 2025
Maintains: Hold
Price Target: $140 → $137
Current: $108.42
Upside: +26.36%
Apr 11, 2025
Maintains: Hold
Price Target: $26 → $24
Current: $16.65
Upside: +44.14%
Feb 10, 2025
Reiterates: Hold
Price Target: $118 → $113
Current: $89.91
Upside: +25.68%
Jan 31, 2023
Maintains: Buy
Price Target: $17 → $21
Current: $15.60
Upside: +34.66%
Aug 24, 2021
Initiates: Outperform
Price Target: $20
Current: $8.39
Upside: +138.38%
Aug 19, 2021
Maintains: Market Perform
Price Target: $71 → $82
Current: $78.83
Upside: +4.02%
Aug 6, 2021
Maintains: Market Perform
Price Target: $260 → $250
Current: $210.02
Upside: +19.04%
May 11, 2021
Maintains: Outperform
Price Target: $27 → $26
Current: $3.77
Upside: +589.66%
Apr 29, 2021
Maintains: Outperform
Price Target: $690 → $770
Current: $187.60
Upside: +310.45%
Apr 29, 2021
Maintains: Outperform
Price Target: $94 → $85
Current: $74.81
Upside: +13.62%
Feb 24, 2021
Initiates: Outperform
Price Target: $20
Current: $12.09
Upside: +65.43%
Feb 23, 2021
Maintains: Outperform
Price Target: $23 → $27
Current: $34.92
Upside: -22.68%